oncoref
  • Home
  • Cancer and Reproductive Antigens
  • Filtering Target candidates
  • Target filter web summary
  • Target filter report
  • Normal-function literature sweep
  • Antigen catalog and curation funnel
  • Curation summary in figures
  • Gene-by-gene sanity review
  • Rare normal-cell RNA by donor
  • Literature review of normal expression
  • Draft catalog 2026-11-09
  • Cancer antigen support audit
  • Thresholds and patient identity
  • Published targets and normal peaks
  • Named CTA placements
  • Expression maxima and Disposable caps
  • Threshold comparison
  • CTA reports
    • CTA definition and illustrated report
    • Translation qualification
    • Verified sequence records
    • Historical evidence dispositions
    • Current release 1.37.0
    • Previous release 1.36.0
    • Complete candidate inventory
    • Candidate evidence explorer and 122-protein review
    • Individual reviews and core paper sources
    • Current paper gaps and representative review
    • Candidate evidence and SSU72L2 prevalence
    • Cancer-only screen and individual normal-tissue reviews
    • CTA gaps and localization release
    • CTA domains and cancer frequency release
    • Transcript default audit
    • Reference protein selection
    • MANE-first selection release
    • Literature and source-role release
    • Previous release 1.29.0
    • Previous release 1.28.0
    • Previous release 1.27.0
    • Simpler decisions and four target reviews
    • Previous release 1.26.0
    • Other protein literature audit
    • Previous release 1.25.0
    • Previous release 1.24.0
    • Previous release 1.23.0
    • Common panel, diffuseness and unassigned proteins
    • ZNF730 calculation tables
    • Paper titles and database versions
    • Human sources, thresholds and funnel
    • Dog sources and funnel coverage
    • Policy simplification and developmental sources
    • Source and decision audit API
    • Historical release 1.21.0
    • Selection API across species
    • Shared screen and antigen sets
    • TCR-T trial evidence and serious events
    • Reviewed 463-group proposal
    • Prior 343-group harmonized funnel
    • PRAME, CTAG2 and TBXT source evidence
    • External staining evidence
    • Brachyury antibody assessment
    • Expanded cohorts and three-way CTA funnel
    • Two-axis thresholds and filtering figures
    • Linked tissue and immune RNA thresholds
    • Uniform quantitative CTA/developmental candidates
    • Historical literature-inclusive CTA catalogue
    • Earlier CTA research selection
    • Current normal-expression breadth
    • Historical normal-expression breadth
    • Cell-RNA thresholds and selection slides
    • Fetal and embryonic target sources
    • Expression policy and protein references
    • Release review and adoption (1.20.0)
    • Versioned sequence-background decisions (25 October)
    • Completed antibody adjudications
    • Literature review and open questions
    • CTA release review and caveats
    • Full CTA evidence atlas and PDFs
    • Previous CTA and Neither review (24 October)
    • Candidate follow-up
    • XAGE5 rescue and antibody review
    • Normal-cell evidence (23 October)
    • Normal-cell data API and rules
    • Previous 589-gene target sets
    • Prior 740-gene screen and Variable evidence
    • Screening rules and API
    • Continuous screen and uncertainty
    • Published curation baseline
    • Reproductive, Normal and Other
    • Disjoint gene and protein sets
    • Continuous screening API
    • Placental CTA sources
    • Bradley CTA audit
  • Tissues
    • Tissue hazard ontology
    • Normal tissue scopes
    • Tissue injury and manageability
    • Patient-context gene filters
    • Normal tissue registry
  • Species
    • Species and data groups
    • Species CTA evidence
  • Data
    • Data versions and reproducibility
    • SRA expression sources
    • HPA cancer reference
    • CTA gene identities
    • Shared reference identities
  • Earlier audits
    • Curation audit
    • Previous selectivity registry
    • Previous tissue registry
    • Previous normal tissue registry
    • CTA tissue scopes
    • CTA permitted tissues
    • CTA IHC-adaptive screen
    • CTA tissue tiers
    • CTA recalibration and complete intake
    • Previous reproductive selectivity
    • Previous tissue priority and IHC grid
    • Previous tissue contexts
  • Figures
  • API guide
  • Search
  • Previous
  • Next
  • Edit on pirl-unc/oncoref
  • CTA evidence guide

CTA evidence guide

Open the filterable candidate table and analysis of the 122 CTAs.

All candidate values · 602 CTAs with biological categories · 122-protein table · Comparison


Documentation built with MkDocs.

Search

From here you can search these documents. Enter your search terms below.

Keyboard Shortcuts

Keys Action
? Open this help
n Next page
p Previous page
s Search